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Green solvents made from glycerol change the classical regioselectivity of Biolacta No 5 -galactosidase, 
from (1→4) toward (1→6) linkages when 2M concentration was used. In order to explain these results, 
the non-proteic compounds present in Biolacta preparation were separated by precipitation with 10 
ammonium sulfate and the remaining protein extract was used to set reactions with appropriate organic 
solvents to find that the regioselectivity towards the β(1 6) isomer is retained. According to proteomic 
analysis, a 98% homology between Streptococcus pneumoniae and Biolacta -galactosidase preparation 
was found. With these data, molecular modelling was done and predicts a tridimensional interaction in the 
enzyme active site with the donor (GlcNAc) and the water-solvent mixture that explains this 15 
phenomenon. 
Introduction 
In recent years, Green Chemistry has become an area of great 
interest for developing more environmentally acceptable 
processes. According to the Green Chemistry principles,1-3 20 
biocatalysis and solvents play an important role in green 
processes, since they provide a valuable alternative to classic 
organic chemistry.4 First, enzymes offer suitable tools for 
industrial reactions, which can be carried out under milder 
conditions, without using of heavy metals and with a great 25 
control over chemo-, regio- and stereoselectivity using 
appropriate enzymes. Second, there are numerous potential 
advantages in employing enzymes in organic solvents, such as 
increased solubility of nonpolar substrates, shifting of 
thermodynamic equilibria to favor synthesis over hydrolysis, 30 
decrease of water-dependent side reactions, enhanced thermal 
stability of enzymes, and elimination of microbial contamination, 
among others.5 On the other hand, the presence of organic 
solvents in enzymatic reactions can alter the activity and 
specificity of the enzyme. There are numerous examples in the 35 
literature wherein solvents physical properties such as dielectric 
constant, dipole moment and hydrophobicity are related to 
various effects on enzyme activity, specificity and 
enantioselectivity.6-9  
Nowadays, a new generation of solvents has been developed, 40 
whose search has become an area of interest. Currently, water, 
supercritical fluids (SCFs), fluorous solvents, and solvents from 
renewable sources are considered green solvents and have been 
used in biocatalysis.10, 11 In that sense glycerol is a green solvent 
that has received attention, especially because it is a by-product 45 
of biodiesel production, and hence it can be obtained from 
renewable sources. Glycerol is an environmentally friendly, non-
toxic, biodegradable solvent. It has already been used in 
biocatalytic reactions, and its potential for these reactions 
demostrated.12-14 50 
On the other hand, oligosaccharides are involved in a wide range 
of biological processes including bacterial and viral infection, 
cancer metastasis, the blood-clotting cascade and many other 
crucial intercellular recognition events.15-18 As the understanding 
of these biological functions increases, the need for practical 55 
synthetic procedures of oligosaccharides in large quantities has 
become a major subject. Organic chemical methods for obtaining 
them have been developed,19-21 but they involve several elaborate 
protection and deprotection procedures. Glycosyl hydrolases 
(glycosidases) can be used to synthesize oligosaccharides in a 60 
kinetically controlled reaction, where a glycosyl donor is used to 
transfer its glycosyl residue to a sugar acceptor present in the 
reaction medium. In spite of the increased amount of work 
carried out with glycosyl hydrolases, their main drawback is the 
lack of regioselectivity, which limits their use for synthetic 65 
purposes. In an important contribution to glycosidase-catalyzed 
oligosaccharide synthesis, Usui et al.22 reported for the first time 
the use of a -galactosidase from Bacillus circulans (Biolacta) to 
synthesize some -D-(1 ) galactosyl disaccharides bearing a 
GlcNAc residue at the reducing end. Some -D-(1→6) linkages 70 
were produced as well, but to the best of our knowledge, it was 
the first time that a preparative scale -D-galactosyltransfer has 
been shown to occur preferentially at the O-4 position using a 
galactosyl hydrolase. Also it has been shown that the use of the 
thioethyl glycoside of N-acetylglucosamine as acceptor and p-75 
nitrophenyl -D-galactoside as donor gave complete selectivity 
for 1 4 transfer23-26. In this work, we present the first study of a 
change of regioselectivity in the enzymatic synthesis of 
disaccharides with Biolacta -galactosidase when green solvents 
derived from glycerol are used. 80 
Results and discussion 
The benchmark reaction used throughout the work has been the 
transglycosilation reaction of N-acetyl glucosamine with p-
nitrophenyl- -D-galactopyranoside, catalyzed by Biolacta Nº 5 -
galactosidase (Scheme 1). This reaction can afford Gal- -(1→4)-85 
GlcNAc as mayor product and Gal- -(1→6)-GlcNAc as minor 
 
product. 
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Scheme 1. General scheme of transglycosilation reaction catalyzed by 
Biolacta N º 5 -galactosidase. 25 
 
Synthesis and toxicity issues of glycerol-derived solvents.  
 
Glycerol-based solvents were synthesized using the same 
procedures previously described.27 The complete listing of the 30 
solvents used in this work is given in Figure 1. Some physico-
chemical and solvatochromic parameters of the solvents used in 
this work are gathered in Table 1. As can be seen, the structural 
diversity of the glycerol derivatives results in a wide range of 
hydrophobicities, covering four orders of magnitude. Bearing this 35 
in mind, a solvent set was selected, since hydrophobicity could be 
a key factor in solvent-enzyme substrate interactions. 
Also, dielectric constants and dipole moments cover a broad 
range of values, as well as the Dimroth–Reichardt solvatochromic 
parameter, ET
N.28 The latter is mainly a measure of the hydrogen-40 
bond donor ability of the solvent, a feature that could also be of 
importance for solvent-substrate and/or solvent-enzyme 
interactions. Some of the glycerol-derived solvents used, namely 
those bearing fluorinated chains, display simultaneously both 
high hydrophobicity and hydrogen-bond donor ability, a rather 45 
unusual combination in conventional organic solvents. 
Miscibility with water, another important issue, also depends on 
solvent structure. Thus, solvents 1–3 are completely miscible 
with water, 5 and 8 are able to dissolve an appreciable amount of 
water. On the other hand, triethers (6 and 9) and highly 50 
fluorinated alcohols (10 and 11) display a very limited 
compatibility with water.27 
Concerning toxicity issues, there are some experimental data 
pointing to glycerol-derived solvents as being low hazardous. For 
instance, toxicities of glycerol-based solvents like 1, 8 and the 55 
closely related 1,3-diethoxy-2-propanol (LD50 > 3000 mg/kg, oral 
in mice)32 and 1,2,3-triethoxypropane (LD50 = 660 mg/kg, 
intraperitoneal in mice)32 are very low, in some cases even lower 
than that of butanol (LD50 = 2680 mg/kg, oral in mice). 
Fluorinated solvents will be probably more toxic than aliphatic 60 
ones, but lacking in experimental data for them it would be 
reasonable to take the toxicities of compounds produced in their 
probable decomposition, like trifluoroethanol (LD50 = 366 mg/kg, 
oral in mice),33 trifluoroacetic acid (LDlo = 150 mg/kg, 
intraperitoneal in mice)33 or 2,2,2-trifluoroethyl ethyl ether (LD50 65 
= 5100 mg/kg, intraperitoneal in rats),34 as referents of the 
toxicity of these kinds of solvents. 
 
Fig. 1 Structure of different solvents derived from glycerol employed in 
the transglycosilation reaction with Biolacta -galactosidase. 70 
 
Moreover using these glycerol derivatives allow to reduce some 
other hazardous aspects. For instance, they have low volatility,27 
so the concentration in the air using them is lower than using 
other conventional solvents. Albeit toxicities of these solvents are 75 
not well known at this moment it is clear they are not extremely 
toxic, meeting one of the key requirements for green applications. 
 
Table 1. Transglycosylation yields (%) obtained with commercial 
Biolacta -galactosidase in presence of green solvents. 80 
 
a Values from ref. 27, unless otherwise indicated. b Value taken from ref. 
30. c Value taken from ref.29. d Value taken from ref.31.                                                                                                                                 
Medium log Pa (D)a a ET
N a Gal 
Disaccharide
-(1 4) 
Disaccharide
-(1 6) 
Buffer 0.00 1.85   - 84 17 
Glycerol –1.33 -   35 14 9 
TFE 0.71 2.64b 27.1c 0.90d 9 73 - 
1 –0.60 3.00 13.0 0.61 - 15 85 
2 0.14 2.40 7.0 0.48 - 23 77 
3 0.27 2.36 6.6 0.44 - 13 87 
4 1.14 3.36 12.0 0.59 - - 93 
5 1.42 4.10 14.6 0.70 - - 100 
6 1.71 4.20 13.7 0.55 79 - 21 
7 1.93 2.30 5.2 0.46 - 17 83 
8 2.07 2.40 5.6 0.45 - - 92 
9 2.48 2.20 4.7 0.15 - 21 71 
10 2.56 3.94 10.4 0.70 57 - 42 
11 3.77 3.90 8.6 0.07 100 - - 
 Enzymatic synthesis in presence of green solvents with 
commercial and semipurified Biolacta –galactosidase.  
Powder of Biolacta Nº5 contains about 11% proteins in its 
composition. After the concentration process we achieved 71% of 
proteins in solid sample, which means we reduce non-proteic 5 
components from the crude preparation. Commercial (C) and 
semipurified (S) enzyme showed a similar specific activity (4.0–
4.2 U mg–1 respectively). SDS-PAGE showed the same gel 
profile elution for the two preparations mentioned above ( Fig. 2). 
 10 
 
 
 
 
 15 
 
 
 
 
 20 
 
 
 
 
 25 
 
 
 
 
 30 
Fig. 2. Electrophoresis gel (7.5%) with different samples 
obtained from Biolacta Nº 5 (S, semipurified; C, commercial). 
 
According to SDS-PAGE results C and S preparation gave about 
11 protein bands in the range of 250–37 kDa, but there are three 35 
important bands at 230, 145 and 86 KDa that is agree with 
previous publication reporting three isoforms in the Biolacta –
galactosidase preparation.35 These suggests that these proteins 
may be assembly in many subunits.(?) ver carta referees 
First, the regioselectivity showed by this enzyme was 40 
investigated when the reaction was carried out in 50 mM 
citrate/phosphate buffer at pH 5.0 (Table 1). Biolacta -
galactosidase gave a mixture of regioisomers, the major -(1→4) 
linker ( 84 % conversion) and minor product -(1→6) linker (17 
%).  45 
 
Second, hydrolytic activity of this -D-galactosidase was 
measured in different concentrations of solvent 1. The best result 
was achieved in 2 M concentration of that solvent (Fig. 3). 
Therefore, transglycosylation reactions catalyzed by commercial 50 
preparation of the Biolacta -galactosidase were carried out in 
buffer media and green solvent (2 M)-buffer mixture (see 
experimental section). Results from these reactions are shown in 
Table 1. 
The synthetic activity of the -galactosidase was examined, and a 55 
change in the regioselectivity of the reaction was confirmed. In 
presence of solvents 1, 4, 5, 8 and 10 the regioisomer -(1→6) 
was formed as the sole product, the best yields being obtained in 
the presence of 4 (93 %), 5 (100 %) and 8 (92%), while with the 
rest of the solvents tested the main product formed was -(1→6) 60 
with yields ranging from 71% to 85 % and -(1→4) as the minor 
product (13–23 %). This change in the regioselectivity had also 
been noticed in previous works by our group in the reaction 
catalyzed by Biolacta -galactosidase, when N,N-dimetylamide-
type solvents were employed.36  65 
 
Fig. 3 Determination of optimal concentration of solvent 1 for the enzyme 
activity of Biolacta -galactosidase at 30ºC (followed by hydrolysis of 
pNP- -Gal).  
 70 
In fact, the change of regioselectivity cannot be easily related to 
the available physical parameters (dipole moment, dielectric 
constant or log P). In principle, it could be due to either solvent-
enzyme or solvent-substrate interactions, as well as to the 
presence of impurities in the enzyme. 75 
 
In order to explain the changes in regioselectivity observed in 
reactions with some solvents and commercial enzyme, most of 
non-proteic substances present in Biolacta were removed by 
precipitation with (NH4)2SO4. The semipurified Biolacta -80 
galactosidase was used with the best green solvents, selected 
accordingly with the previous results obtained with the 
commercial enzyme. Table 2 shows the yields obtained in 
different media for these reactions.  
Table 2. Transglycosylation yields (%) obtained with semipurified 85 
Biolacta -galactosidase in the presence of glycerol-derived solvents. 
 
Medium Hydrolysis 
(galactose) 
Synthesis 
(1  4) 
Synthesis 
(1  6) 
Buffer - 90 10 
4 6 6 88 
5 14 11 75 
8 9 9 82 
 
Using semipurified enzyme we observed that solvent 4 leads to 
the best yields for Gal (1 6)GlcNAc product. This result 90 
represents a very important regioselectivity change in comparison 
with the natural behavior of this enzyme that shows a high 
tendency to give Gal (1  4)GlcNAc product.24-26  
Using commercial or semipurified enzyme as catalyst in buffer 
medium usually gives ride to yields about 80% or 90% (1 4) 95 
and 17 or 10% (1 6) product (See Table 1 and 2). Finally, and 
taking into account that this reaction was performed after 
elimination of non-proteic substances present in Biolacta, one can 
conclude that those substances were not related to regioselectivity 
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changes observed during transglycosylation reactions and could 
be related to molecular interactions between enzyme, solvent and 
substrates. 
 
Molecular modeling studies 5 
 
In order to analyze the proteic nature of the commercial Biolacta 
-galactosidase a spot from the SDS-PAGE (approximately 86 
kDa) was selected according to the molecular mass expected for 
the -galactosidase for Biolacta crude extract35 and the and the 10 
mass spectrometry  analysis of the protein spots was done. 
Results from the proteomic analysis showed 98% homology with 
Streptococcus pneumoniae SP9-BS68 -galactosidase, which 
posses a 247 kDa molecular mass. This information could explain 
the synthetic behavior of Biolacta enzymes with high preference 15 
to Gal- (1 4)GlcNAc synthesis instead of the classical B. 
circulans tendency toward (1 3) linkages37, 38 that does not 
occur in Biolacta preparation.  
 
The S. pneumoniae -galactosidase have proved to be more 20 
selective for catabolic degradation of Gal- (1 4)GlcNAc than 
lactose because its role in infection processes.39, 40 This feature is 
also present in Biolacta crude extract and suggests that both could 
be indeed the same enzyme. These data also support the idea that 
protein conglomerates are present in Biolacta preparation and 25 
they are cleaved by denaturing conditions of SDS-PAGE. 
 
In order to come up with a rational explanation and to confirm 
our hypothesis about the influence of the solvent properties in 
reaction stereoselectivity in the glycosidic linkage formation, 30 
molecular modeling studies were carried out. 
 
A 3D β-galactosidase S. pneumoniae model was build and the 
molecules implicated in the mechanism docked, then, MD 
simulations were run in two different solvent conditions and the 35 
results compared. 
 
The active site was located using a combination of sequence and 
structure alignment and blind docking. The enzyme model 
revealed that the active center could be similar to E. coli lacZ. A 40 
simple superimposition of the structure of a monomer and the 
model yielded the identification of the catalytic pair (Glu-564 and 
Glu-645) and the chemical behavior of each of them. Residue 
Glu-645 corresponds to Glu-537 in lacZ which is accepted as the 
nucleophile,41 while Glu-564 was identified as the acid catalyst. 45 
This fact is also consistent with the first docking results. 
It was observed that the compound tended to be located near the 
Glu-645 residue, packed over the Trp-708 residue. This kind of 
interaction has been deeply investigated42 and it is identified as 
crucial for other galactosidases. Additional interactions with 50 
residues His-450, His-484, Asn-563 and Glu-716 contribute to 
stabilize the molecule as seen in Fig. 4. 
 
After modeling the glycosyl-enzyme, GlcNAc was docked in the 
active site. The best docking solution was used as a starting point 55 
for MD simulations. Regarding to the preferred stereochemistry 
of β-galactosidases, distances between anomeric carbon (C1) and, 
4 and 6 hydroxyl groups (O4 and O6) of the acceptor molecule, 
were shown to be valid indicators of the carbon atom in the best 
position to be attacked and correlated with the regiospecificity of 60 
various enzyme used in the enzymatic synthesis of 
carbohydrates.43  
 
With this aim, the distances between the C1 and O4 and O6 
groups and between oxygen atoms of Glu-564 and protons of 65 
each hydroxyl group were measured. Special attention was paid 
for structural information in the active site, particularly for 
differential binding mode between simulations that could explain 
the change in the stereoselectivity. Average distances are 
presented in table 3 together with RMSD of alpha carbons. 70 
 
Table 3. Average distances (in Å) between anomeric carbon (C1) and 
hydroxyl groups (O4 and O6) and RMSD of the simulation. 
 
 C1-O6 C1-O4 COO–-HO-C6 COO–-HO-C4 RMSD C  (Å) 
Water 5.76a 5.26a 5.73a 5.81a 2.27 
5-Water 4.79 7.89 7.42 8.93 1.93 
a After change of position. 75 
 
Although the docked solution showed a clear preference for O6, 
not compatible with the experimental product, during the MD 
simulation the distances from the anomeric carbon to O4 and O6 
changed at 700 ps, indicating a variation in the configuration of 80 
the acceptor. Indeed, a different binding mode can be observed, 
in which the acceptor is found deeper in the active center, 
interacting mainly with Tyr-624 and Lys-664.  
This change could be a consequence of a pushing effect of the 
solvent (water) due to the hydrophobic nature of the acetyl chain, 85 
which can be found interacting with Tyr-624. The distance C1-
O4 was found to be more favorable; nevertheless, O6 is still close 
enough to allow both linkages as determined experimentally. 
 Fig. 4. Binding modes: Shallow mode in 5-water simulation at left, deep mode in water simulation on the right. 
 
In the case of solvent 5-water mixture, the initial docked solution 
was found to be coincident with the experimental product. The 5 
acceptor exhibited during the entire simulation a clear preference 
for O6, supporting the formation of the β(1 6) linkage. 
However, a key interaction present in this complex, the residue 
Ser-648, is found to be interacting with O4 hydroxyl of the 
acceptor. This interaction is not present in the water simulation 10 
because of the deep binding mode of the molecule and it could 
contribute to the stabilization of the complex. In this case, the 
acetyl chain is not pushing deeper the acceptor. Apparently, the 
interaction with the solvent is not as unfavorable as in the case of 
water only, and the molecule adopts a shallow binding mode with 15 
essentially the same interactions of the deep binding mode (Tyr-
624 and Lys-664) with the additional interaction with Ser-648. 
The distances measured during MD simulations are correlated 
with the experimental results, in which the formation of β(1 6) 
linkage is expected in 5-water mixture, while the β(1 4) linkage 20 
is the main product in water with some β(1 6) linked molecules. 
In the superimposition of both solutions (water and 5-water 
mixture, Fig. 5) can be appreciated that O4wat and O65-wat are 
located in the same position, at a good distance from C1 and the 
catalytic Glu-564. 25 
 
The role of the acceptor in the stereochemical changes in 
carbohydrate enzymatic synthesis is of great importance as it has 
been previously reported.38 Particularly, some groups attached to 
the acceptor could help to get the substrate molecule closer to the 30 
catalytic residues and induce a change in the sugar conformation. 
This is the case of the 2-acetamido group,38 which greatly 
influences the stereoselectivity of the overall reaction. In our 
system, the interaction between the acetyl chain and the solvent 
triggers a binding mode change in which the molecule may reach 35 
a deep position in the active center, improving the O4/O6 groups 
accessibility, and therefore, the stereochemistry. The differences 
between solvents may be explained by the different size and 
characteristics of the derivatives that may be the final responsible 
of the interaction with the acceptor. 40 
 
 
Fig. 5 Superimposition of the two binding modes: shallow (in green) and 
deep (in yellow). Catalytic residues are shown in light blue. 
Superimposition of O6 (shallow) and O4 (deep) can be observed. 45 
Conclusions 
In this work we determined a change in classical regioselectivity 
of Biolacta -D-galactosidase when reaction is performed in the 
presence of glycerol-based solvents. These solvents promote the 
(1 6) linkages between donor and acceptor instead of (1 4). 50 
This reactivity change is maintained even after the Biolacta non 
protein components are removed, which means the change is 
mainly related to enzyme-solvent interactions. The proteomic 
analysis showed a high similarity between S. pneumoniae -D-
galactosidase and one of Biolacta proteins, which could explain 55 
the tendency toward (1 4) linkages present in both enzymes. 
Using S. pneumoniae protein structure as a basis for 
understanding the solvent-enzyme interaction, we undertook a 
 
molecular modeling study and found that the three-dimensional 
arrangement between GlcNAc and the water-solvent (5) mixture 
in the active site of the enzyme, favors the (1 6) linkage. This 
disposition is also stabilized by the OH interaction between Ser-
648 and O4 from GlcNAc, which also explains the reduced 5 
proportion of (1 4) linkage product. 
Experimental  
Materials. p-nitrophenol (pNP), p-nitrophenyl- -D-
galactopyranoside (pNP- -Gal), N-acetyl-D-glucosamine 
(GlcNAc), Gal- (1 4)GlcNAc, Gal- (1 6)GlcNAc, D-(+)-10 
galactose, ammonium sulfate and bovine serum albumin (BSA), 
were purchased from Sigma Aldrich. Biolacta Nº5 β-
galactosidase from B. circulans was received from Daiwa Kasei, 
Japan. Dye reagent for protein determination was purchased from 
Bio Rad. All other chemicals were from analytical grade.  15 
UV-visible spectra were recorded on a UV-2401 PC Shimadzu. 
HPLC Agilent 1100 with UV-vis detector using 
Mediterraneasea18 15 cm x 0.46 5 mm column (Teknokroma) 
with water: acetonitrile (75:25) as a mobile phase at a flow of 0.7 
mL min–1. HPLC Jasco with an evaporative light scattering 20 
detector (ELSD) using NH2P50-4E amino column (Asahipak, 
Japan) with acetonitrile: water (80:20) as a mobile phase at a flow 
of 1.0 mL min–1. NMR spectra were recorded on Bruker AV 500 
MHz spectrometers. The structures of the enzymatically 
synthesized disaccharides were assigned by 1H, 13C and 2-D 25 
NMR (see Supporting Information for details). 
 
Enzyme assays. Hydrolytic activity was determined by 
spectrophotometrical quantification of pNP liberated from pNP-
-Gal in citrate/phosphate buffer 50 mM, pH 5.0, using both 30 
continuous and discontinuous methods. Continuous method: 
hydrolysis of pNP- -Gal (5 mM) in a 1 L cell by measuring the 
increase in absorbance at 410 nm during 2.5 minutes at 37ºC.44 
Discontinuous method: hydrolysis of 200 L of pNP- -Gal (1.0 
mM) for 10 minutes at 37ºC and then reaction was stopped by 35 
adding 1.00 mL of Na2CO3 0.20 M.
44,36 Each experimental assay 
was determined at least three samples with standard deviation 
under 5% of the average of samples. Protein concentration was 
determined by Bradford method45 following  the manufacturer’s 
protocol (Bio-Rad) and bovine serum albumin as the standard. 40 
One enzymatic unit was defined as the amount of protein that 
hydrolyses 1 mol of p-nitrophenyl- -D-galactopyranoside per 
minute under the conditions described before.  
 
Semipurification of enzymes. Semipurified Biolacta -45 
galactosidase was obtained as a precipitate by centrifugation after 
the addition of ammonium sulfate, (55% saturation at 0ºC) to a 
solution of 5% m/v from commercial enzyme in citrate/phosphate 
buffer 50 mM, pH 5.0,. The pellet was resuspended in in 
citrate/phosphate buffer 50 mM, pH 5.0. 50 
 
Proteomic Analysis. In order to identify proteic nature of the -
galactosidases present in the commercial Biolacta preparation, a 
spot from the SDS-PAGE46 (7,5%) was selected according to the 
molecular relative mass for this enzyme described by Vetere and 55 
Paoleti.42 Sample was sent to Proteomic Unit Services at 
Universidad Complutense. The protein was identified by peptide 
mass fingerprints and MS/MS sequencing analyses. Homology 
search of the sequences was obtained by Blast 
(http://www.ncbi.nlm.nih.gov/BLAST). 60 
 
Glycerol-derived solvents. Glycerol-based solvents were 
synthesized using the same procedures previously described.27 
The alcoholysis of either epichlorohydrin (symmetrical 
derivatives) or the appropriate glycidol ether (unsymmetrical 65 
derivatives), gave the corresponding 1,3-dialkoxy-2-propanols. 
O-methylation of some selected targets leads to the corresponding 
1,2,3-trialkoxypropanes. All the solvents were purified by 
distillation and used in high pure form. The complete listing of 
the solvents used in this work is given in Fig 1. 70 
 
Effect of solvent molarity on enzyme activity. In order to 
determine the molarity of green solvent required for the 
transglycosylation reactions we measured the hydrolytic rates of 
the crude enzyme using solvent 1 in the following concentrations: 75 
2, 4, 6 and 8 M. The hydrolysis measurements were performed by 
quantification of the p-nitrophenyl- -D-galactopiranoside by UV-
visible detector on HPLC. 
 
Transglycosylation reactions. Transglycosylation reactions 80 
were carried out using commercial preparations and semipurified 
enzymes. To begin with, solvents from 1 to 11 were employed 
with a commercial crude extract of the enzyme. Then, the best 
solvents were chosen according to best performance and used to 
carry out reactions with semipurified enzymes in order to 85 
determine the effect of non-proteic substances present in Biolacta 
preparation in reaction yields. 
A 0.17 M solution pNP- -Gal (donor) 0.85 M of GlcNAc 
(acceptor) in 1 mL of green solvent (2 M)-buffer mixture was 
pre-equilibrated to 30 ºC. Afterwards, 155 mol min–1 (U) of 90 
Biolacta -galactosidase were added to the reaction mixture. 
Reaction was monitored by HPLC UV-visible, and final products 
obtained were analyzed by HPLC-ELSD. The reaction was 
stopped by heating to 100 ºC for 5 min.  
The reaction mixture was then directly loaded onto a carbon-95 
celite column. The column was first eluted with water (200 mL) 
and then with a linear gradient of 0% to 15% (v/v) of ethanol. 
Solvents were eliminated and disaccharides were dissolved in 
D2O to be characterized by H
1 and C13 NMR spectroscopy. 
Molecular modeling studies. Upon information available, 100 
molecular modeling studies were carried out to explain 
interactions between glycerol-based solvents and substrates as 
well as solvents-enzyme interactions. 
Homology modeling. According to the results obtained with the 
peptide mass fingerprint, Streptococcus pneumoniae -105 
galactosidase was selected as the starting point for the molecular 
modeling studies. The 3D model of the domain with catalytic 
activity of this β-galactosidase (residues 150–979) was built by 
homology modeling based on available crystal structures of 
homologous proteins. The complete amino acid sequence of the 110 
target protein was retrieved from NCBI protein sequence 
database (Accession No. gi|148992245) in FASTA format. The 
NCBI Basic Local Alignment Search Tool (BLAST),47 for 
sequence similarities was used for searching the crystal structures 
of the closest homologues available in the Brookhaven Protein 115 
 Data Bank (PDB). The results revealed β-galactosidase from 
Bacteroides vulgatus (PDB ID: 3GM8), with a resolution of 2.4 
Å, was a suitable template (81% of homology in the selected zone 
and E-value 2e-104). 
The sequences of β-galactosidases from B. vulgatus, B. fragilis, 5 
B. thetaiotaomicron and E. coli, which were the most similar to 
that of S. pneumoniae, were used for a pairwise alignment 
employing the Multiple Sequence Comparison by Log-
Expectation (MUSCLE) tool.48  
Homology modeling of the target was performed by two 10 
automated homology modeling servers: SWISS-MODEL49 and 
3D-JIGSAW50 using as template the protein 3GM8. The first was 
found the best model, and was selected after performing a the 
1000 steps of steepest descent (SD) energy minimization using 
the GROMOS 96 force field and GROMACS 4.0.3 package,51 to 15 
regularize the protein structure geometry. 
The quality of the model was analyzed with the PROCHECK52 
program to calculate the main-chain torsional angles 
(Ramachandran plot) and it was verified using the on-line 
software ERRAT53 and VERIFY_3D54 at the UCLA-DOE 20 
Structure Analysis and Verification Server (http://www.doe-
mbi.ucla.edu/Services/SV/). Most of the analyzed parameters had 
statistical values that were in the range of those expected for a 
naturally folded protein and therefore, the model was considered 
validated. 25 
Active site search. The absence of a crystal structure of the 
complex forced us to deduce the location of the active center by 
means of conservation analysis of residues, blind docking and 
structure superimposition.  
A comparative analysis of the catalytic residues of resolved 30 
structures (lacZ E. coli) yielded as a result a perfect conservation 
of two glutamic acid residues, Glu-564 and Glu-645, 
corresponding with residues 461 (acid catalyst) and 537 
(nucleophile) in the lacZ of E. coli.41 The structure of the chain A 
of lacZ (PDB ID: 1PX3) was superimposed on the model using 35 
PyMOL. A very good superimposition of the analyzed residues 
could be observed depicting a typical active center of β-
galactosidase in which the two glutamic residues were placed at a 
distance of 5.5 Å, the usual distance for this class of enzymes. 
Finally, a blind docking using the whole structure as the grid was 40 
performed, and the results confirmed the hypothetic active site. 
Molecular docking. As in previous work a two43 dockings 
approach was followed. A p-nitrophenol-β-galactopiranose was 
initially docked into the active center to determine to the position 
of the molecule to simulate the glycosyl-enzyme intermediate. 45 
With this aim, we selected the best pose according the 
geometrical (close enough to the nucleophile Glu-645) and 
energetic criteria (favorable energy) and set up a covalent link 
between the Glu-645 residue and the galactose. 
Regarding the second docking, the glycosyl-enzyme was used to 50 
perform a docking with the N-acetyl-glucosamine (GlcNAc), the 
best solution was selected taking into account energetic criteria 
only, and it was taken as starting structure for the subsequent 
molecular dynamics studies. 
All docking procedures were carried out with Autodock 4 55 
software,55 using a 60x60x60 grid points box around Glu-645 
residue, to embrace all residues implicated in the mechanism, and 
with a grid spacing of 0.375 Å. A Lamarckian genetic algorithm 
with the standard parameters was selected. 
Solvent parameterization. One of the experimental solvents, 60 
namely 1,3-bis(2,2,2-trifluoroethoxy)propan-2-ol (5) was used to 
solvate the protein and simulate the system in order to model the 
change in the stereoselectivity induced by the solvent and get 
insights into the molecular details of this process. Due to the lack 
of parameters for 5 for the GROMOS 96 43a1 force field, a 65 
parameterization of this molecule was carried out. The structure 
was optimized within the density functional theory (DFT) 
framework, at the B3LYP/6-31G** level, using the Massively 
Parallel Quantum Chemistry package (MPQC).56 All the 
parameters (bond lengths, angles and dihedrals) and charges were 70 
extracted from the calculations or from the standard force field.57  
To check the derived parameters, a test system was set up formed 
by a cubic box of 216 molecules of 5. This box was equilibrated 
300 ps at 298K and 1 atm. Following, a production simulation of 
5 ns was carried out at the same NpT conditions recording 75 
position and energy values every 1 ps. Finally, density was 
calculated and compared with the experimental values,58 
confirming a good agreement (ρexp=1330 Kg m
–3;29 ρcalc=1360 Kg 
m–3). 
Molecular dynamics. Molecular dynamics simulations were set 80 
up with the best solution of docking and the glycosyl-enzyme 
intermediate. Parameters adopted in GROMOS 96 43a1 were 
used for the protein, while the parameters required for the 
galactose-glutamic residue were derived in a consistent manner 
with the force field. GlcNAc parameters were extracted from 85 
Dundee PRODRG 2.5 Server (beta) 
(http://davapc1.bioch.dundee.ac.uk/cgi-bin/prodrg_beta) and the 
charges were properly checked.  
An initial minimization of the complex was performed with 500 
steps of SD followed by 1500 steps of Polak-Ribiere Conjugate 90 
Gradients (CG). The minimized complex was solvated in two 
different cubic boxes, fulfilling the requirement of a minimum 
distance of 1.2 nm between any atom of the complex and the 
faces of the box. The first box was filled with SPC water 
molecules to reproduce the usual experimental conditions for the 95 
enzyme, while the second one was filled with a mixture of SPC 
water molecules and 5 molecules trying to reproduce the 
conditions for the stereochemistry change presented in this work. 
Then, for each box, a new minimization procedure of 500 steps of 
SD and 3000 steps of CG was followed. The systems were 100 
equilibrated 100 ps at 298K (NVT conditions) and another 100 ps 
at 298K and 1 atm (NPT conditions). Finally, 1 ns production 
simulations were carried out. 
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